CliffBio
small molecule

METHYCLOTHIAZIDE

METHYCLOTHIAZIDE

Loss of exclusivity—loss of exclusivity
CompanyPar →See this company's full patent-cliff portfolio

Drug detail

Brand nameMETHYCLOTHIAZIDE
Active ingredientMETHYCLOTHIAZIDE
Strength5MG
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalFebruary 1986
Marketing statusDISCN

More from Par

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

METHYCLOTHIAZIDE patent cliff — loss of exclusivity — | CliffBio